3D3Z
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 3d3z by Molmil](/molmil-images/mine/3d3z) | Crystal structure of Actibind a T2 RNase | Descriptor: | 1,2-ETHANEDIOL, 1-(5-deoxy-beta-L-xylofuranosyl)pyrimidine-2,4(1H,3H)-dione, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Gonzalez, A, Almog, O. | Deposit date: | 2008-05-13 | Release date: | 2009-06-02 | Last modified: | 2023-08-30 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Crystal structue of Actibind a T2 RNase To be Published
|
|
3TBJ
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 3tbj by Molmil](/molmil-images/mine/3tbj) | The 1.7A crystal structure of Actibind a T2 ribonucleases as antitumorigenic agents | Descriptor: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Almog, O, Gonzalez, A. | Deposit date: | 2011-08-07 | Release date: | 2012-08-22 | Last modified: | 2020-07-29 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | The 1.8 A crystal structure of ACTIBIND suggests a mode of action for T2 ribonucleases as antitumorigenic agents. J.Med.Chem., 55, 2012
|
|